Shots:

• Translate Bio will utilize its mRNA platform to discover- design- and manufacture SARS-CoV-2 vaccine candidates while Sanofi will provide its vaccine expertise in advancing the vaccine candidates for further development
• The collaboration leverages the existing 2018 agreement signed b/w the companies for developing mRNA vaccines for infectious diseases
• The collaboration marks the Sanofi’s second collaboration for developing vaccine candidates against COVID-19. Initially- the company has collaborated with BARDA to advance vaccine candidates in Feb’2020

Click here ­to­ read full press release/ article | Ref: Sanofi | Image: WFMZ